title: Wasting cash--the decline of the British biotech sector.
abstract: Undercapitalization and overgenerous boardroom compensation for management have been major contributors to the poor performance of UK biotech.
authors.forename: Graham
authors.initials: G
authors.lastname: Smith
authors.forename: Muhammad Safwan
authors.initials: MS
authors.lastname: Akram
authors.forename: Keith
authors.initials: K
authors.lastname: Redpath
authors.forename: William
authors.initials: W
authors.lastname: Bains
mesh_terms: D001709:Biotechnology / Q000191:economics*; D002202:Capital Financing / Q000191:economics; D006801:Humans; D017149:Private Sector; D012456:Salaries and Fringe Benefits; D006113:United Kingdom